

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of skin barrier (GO:0061436) | 8.17164621 |
| 2 | regulation of water loss via skin (GO:0033561) | 7.51273231 |
| 3 | cellular response to nitric oxide (GO:0071732) | 6.17411268 |
| 4 | keratinization (GO:0031424) | 6.08038208 |
| 5 | neurofilament cytoskeleton organization (GO:0060052) | 5.76541895 |
| 6 | intermediate filament organization (GO:0045109) | 5.69026324 |
| 7 | NADH metabolic process (GO:0006734) | 5.68238310 |
| 8 | multicellular organismal water homeostasis (GO:0050891) | 5.57107989 |
| 9 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.38382099 |
| 10 | sphingoid metabolic process (GO:0046519) | 5.09182604 |
| 11 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.78130611 |
| 12 | glutathione biosynthetic process (GO:0006750) | 4.78107803 |
| 13 | water homeostasis (GO:0030104) | 4.77408919 |
| 14 | sphingosine metabolic process (GO:0006670) | 4.66739633 |
| 15 | keratinocyte proliferation (GO:0043616) | 4.59985946 |
| 16 | cellular response to reactive nitrogen species (GO:1902170) | 4.47116527 |
| 17 | keratinocyte differentiation (GO:0030216) | 4.44116269 |
| 18 | hemidesmosome assembly (GO:0031581) | 4.40564009 |
| 19 | response to nitric oxide (GO:0071731) | 4.35774172 |
| 20 | regulation of ruffle assembly (GO:1900027) | 4.31067644 |
| 21 | diol metabolic process (GO:0034311) | 4.29021675 |
| 22 | phospholipid scrambling (GO:0017121) | 4.23427335 |
| 23 | angiotensin maturation (GO:0002003) | 4.15063791 |
| 24 | drug transmembrane transport (GO:0006855) | 4.13220887 |
| 25 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.10990210 |
| 26 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.96659192 |
| 27 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.96659192 |
| 28 | detection of temperature stimulus (GO:0016048) | 3.88317585 |
| 29 | epoxygenase P450 pathway (GO:0019373) | 3.87958105 |
| 30 | intermediate filament cytoskeleton organization (GO:0045104) | 3.86818034 |
| 31 | peptide cross-linking (GO:0018149) | 3.84434311 |
| 32 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.81921303 |
| 33 | intermediate filament-based process (GO:0045103) | 3.79772891 |
| 34 | response to vitamin A (GO:0033189) | 3.76576877 |
| 35 | amyloid precursor protein metabolic process (GO:0042982) | 3.74990855 |
| 36 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.74149406 |
| 37 | protein retention in ER lumen (GO:0006621) | 3.72370727 |
| 38 | fatty acid elongation (GO:0030497) | 3.66571859 |
| 39 | organic cation transport (GO:0015695) | 3.66337341 |
| 40 | urate metabolic process (GO:0046415) | 3.65672474 |
| 41 | positive regulation of glomerulus development (GO:0090193) | 3.61535958 |
| 42 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.60738248 |
| 43 | response to water (GO:0009415) | 3.59841429 |
| 44 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.51754833 |
| 45 | epidermal cell differentiation (GO:0009913) | 3.51054949 |
| 46 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.48064812 |
| 47 | regulation of G0 to G1 transition (GO:0070316) | 3.44978493 |
| 48 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.44205023 |
| 49 | epithelial cell-cell adhesion (GO:0090136) | 3.40655249 |
| 50 | glycosphingolipid catabolic process (GO:0046479) | 3.37975717 |
| 51 | cell communication involved in cardiac conduction (GO:0086065) | 3.37457979 |
| 52 | vitamin transmembrane transport (GO:0035461) | 3.36571413 |
| 53 | Golgi transport vesicle coating (GO:0048200) | 3.34734125 |
| 54 | COPI coating of Golgi vesicle (GO:0048205) | 3.34734125 |
| 55 | peptide biosynthetic process (GO:0043043) | 3.32652431 |
| 56 | protein autoprocessing (GO:0016540) | 3.32180151 |
| 57 | drug catabolic process (GO:0042737) | 3.31995954 |
| 58 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.31454478 |
| 59 | membrane budding (GO:0006900) | 3.30793988 |
| 60 | drug transport (GO:0015893) | 3.28332853 |
| 61 | exogenous drug catabolic process (GO:0042738) | 3.26799480 |
| 62 | regulation of cholesterol esterification (GO:0010872) | 3.25543761 |
| 63 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.22894570 |
| 64 | response to thyroid hormone (GO:0097066) | 3.21548301 |
| 65 | sexual reproduction (GO:0019953) | 3.20270226 |
| 66 | glycolipid catabolic process (GO:0019377) | 3.18917252 |
| 67 | virion attachment to host cell (GO:0019062) | 3.16391128 |
| 68 | adhesion of symbiont to host cell (GO:0044650) | 3.16391128 |
| 69 | adhesion of symbiont to host (GO:0044406) | 3.14976934 |
| 70 | prostaglandin biosynthetic process (GO:0001516) | 3.14624001 |
| 71 | prostanoid biosynthetic process (GO:0046457) | 3.14624001 |
| 72 | regulation of hippo signaling (GO:0035330) | 3.13777493 |
| 73 | quaternary ammonium group transport (GO:0015697) | 3.11514663 |
| 74 | glucosamine-containing compound catabolic process (GO:1901072) | 3.10421677 |
| 75 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.08631389 |
| 76 | proline metabolic process (GO:0006560) | 3.06071444 |
| 77 | urea cycle (GO:0000050) | 3.05658462 |
| 78 | flavonoid metabolic process (GO:0009812) | 3.04908081 |
| 79 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.04715962 |
| 80 | epidermis development (GO:0008544) | 3.03336511 |
| 81 | regulation of phospholipase A2 activity (GO:0032429) | 3.01717313 |
| 82 | proline biosynthetic process (GO:0006561) | 2.98695535 |
| 83 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.98518779 |
| 84 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.98396411 |
| 85 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.97436620 |
| 86 | GDP-mannose metabolic process (GO:0019673) | 2.97145976 |
| 87 | sodium ion export (GO:0071436) | 2.95170548 |
| 88 | phenylpropanoid metabolic process (GO:0009698) | 2.95076494 |
| 89 | response to phenylpropanoid (GO:0080184) | 2.93391938 |
| 90 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.90393627 |
| 91 | hormone catabolic process (GO:0042447) | 2.88053975 |
| 92 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.87731866 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 2.87717021 |
| 94 | regulation of cardioblast differentiation (GO:0051890) | 2.87413084 |
| 95 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.87372992 |
| 96 | toxin metabolic process (GO:0009404) | 2.87280977 |
| 97 | phospholipid efflux (GO:0033700) | 2.87233081 |
| 98 | regulation of cholesterol metabolic process (GO:0090181) | 2.86751111 |
| 99 | norepinephrine metabolic process (GO:0042415) | 2.86360252 |
| 100 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.85037299 |
| 101 | 4-hydroxyproline metabolic process (GO:0019471) | 2.84968172 |
| 102 | negative regulation of lipase activity (GO:0060192) | 2.83735221 |
| 103 | atrioventricular valve morphogenesis (GO:0003181) | 2.82800285 |
| 104 | phosphate ion transmembrane transport (GO:0035435) | 2.82410062 |
| 105 | chemical homeostasis within a tissue (GO:0048875) | 2.81853505 |
| 106 | protein maturation by protein folding (GO:0022417) | 2.81134814 |
| 107 | embryonic process involved in female pregnancy (GO:0060136) | 2.80982491 |
| 108 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.80798513 |
| 109 | phosphate ion transport (GO:0006817) | 2.80494527 |
| 110 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.78731403 |
| 111 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.78118878 |
| 112 | plasma membrane repair (GO:0001778) | 2.77476043 |
| 113 | urea metabolic process (GO:0019627) | 2.76985587 |
| 114 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.76946404 |
| 115 | lipoprotein transport (GO:0042953) | 2.76767781 |
| 116 | lysine catabolic process (GO:0006554) | 2.76533696 |
| 117 | lysine metabolic process (GO:0006553) | 2.76533696 |
| 118 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.75877599 |
| 119 | amyloid precursor protein catabolic process (GO:0042987) | 2.75201632 |
| 120 | drug metabolic process (GO:0017144) | 2.74784167 |
| 121 | detection of bacterium (GO:0016045) | 2.74393945 |
| 122 | positive regulation of vesicle fusion (GO:0031340) | 2.72395698 |
| 123 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.69254170 |
| 124 | cell migration in hindbrain (GO:0021535) | 2.69127163 |
| 125 | fructose metabolic process (GO:0006000) | 2.68484498 |
| 126 | excretion (GO:0007588) | 2.68047805 |
| 127 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.68047305 |
| 128 | tight junction assembly (GO:0070830) | 2.67709256 |
| 129 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.67562094 |
| 130 | interferon-gamma secretion (GO:0072643) | 2.64518291 |
| 131 | response to copper ion (GO:0046688) | 2.64496481 |
| 132 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.64400037 |
| 133 | apoptotic process involved in morphogenesis (GO:0060561) | 2.63974906 |
| 134 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.62406827 |
| 135 | regulation of bile acid biosynthetic process (GO:0070857) | 2.62250137 |
| 136 | negative regulation of complement activation (GO:0045916) | 2.61971128 |
| 137 | regulation of glomerulus development (GO:0090192) | 2.60961126 |
| 138 | ceramide catabolic process (GO:0046514) | 2.60296753 |
| 139 | renal absorption (GO:0070293) | 2.59945641 |
| 140 | renal system process involved in regulation of blood volume (GO:0001977) | 2.58872244 |
| 141 | phosphate ion homeostasis (GO:0055062) | 2.58338671 |
| 142 | trivalent inorganic anion homeostasis (GO:0072506) | 2.58338671 |
| 143 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.57024653 |
| 144 | adherens junction assembly (GO:0034333) | 2.57016719 |
| 145 | negative regulation of kidney development (GO:0090185) | 2.56375324 |
| 146 | transepithelial transport (GO:0070633) | 2.56186588 |
| 147 | fatty acid derivative transport (GO:1901571) | 2.55753985 |
| 148 | icosanoid transport (GO:0071715) | 2.55753985 |
| 149 | regulation of glomerular filtration (GO:0003093) | 2.55492898 |
| 150 | membrane raft organization (GO:0031579) | 2.52175382 |
| 151 | ectoderm development (GO:0007398) | 2.51899446 |
| 152 | cysteine metabolic process (GO:0006534) | 2.51384081 |
| 153 | cellular potassium ion homeostasis (GO:0030007) | 2.51328473 |
| 154 | peripheral nervous system neuron development (GO:0048935) | 2.50312235 |
| 155 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.50297642 |
| 156 | sphingomyelin metabolic process (GO:0006684) | 2.49970974 |
| 157 | carnitine transport (GO:0015879) | 2.49773619 |
| 158 | amino-acid betaine transport (GO:0015838) | 2.49773619 |
| 159 | protein-lipid complex assembly (GO:0065005) | 2.48796612 |
| 160 | omega-hydroxylase P450 pathway (GO:0097267) | 2.48490844 |
| 161 | surfactant homeostasis (GO:0043129) | 2.46821258 |
| 162 | molting cycle (GO:0042303) | 2.45503429 |
| 163 | hair cycle (GO:0042633) | 2.45503429 |
| 164 | neuronal action potential (GO:0019228) | 2.43417019 |
| 165 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.41605523 |
| 166 | beta-amyloid metabolic process (GO:0050435) | 2.40601484 |
| 167 | peptide catabolic process (GO:0043171) | 2.39872383 |
| 168 | cellular modified amino acid catabolic process (GO:0042219) | 2.37365426 |
| 169 | sodium ion transport (GO:0006814) | 2.35687235 |
| 170 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.34726902 |
| 171 | very long-chain fatty acid metabolic process (GO:0000038) | 2.34677063 |
| 172 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.33936129 |
| 173 | sodium ion homeostasis (GO:0055078) | 2.31782852 |
| 174 | sympathetic nervous system development (GO:0048485) | 2.31422743 |
| 175 | glutathione metabolic process (GO:0006749) | 2.31272869 |
| 176 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.31129243 |
| 177 | skin morphogenesis (GO:0043589) | 2.30807475 |
| 178 | vitamin D metabolic process (GO:0042359) | 2.28441559 |
| 179 | lipoxygenase pathway (GO:0019372) | 2.28178168 |
| 180 | sodium-independent organic anion transport (GO:0043252) | 2.27680621 |
| 181 | response to mercury ion (GO:0046689) | 2.27361270 |
| 182 | regulation of cholesterol homeostasis (GO:2000188) | 2.25951694 |
| 183 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.24861486 |
| 184 | sodium ion transmembrane transport (GO:0035725) | 2.23955564 |
| 185 | desmosome organization (GO:0002934) | 10.4031345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.57914697 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.67293959 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.47700789 |
| 4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.78880583 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.62955570 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.53827173 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19320265 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.18340180 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.07377518 |
| 10 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.06940535 |
| 11 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.06323640 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.95376435 |
| 13 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.92738523 |
| 14 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.85406948 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.71288613 |
| 16 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.70299412 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.62040872 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.58958300 |
| 19 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.55514171 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53953096 |
| 21 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.52822571 |
| 22 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52358407 |
| 23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51850972 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.51848879 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.51388128 |
| 26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51036521 |
| 27 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.50982154 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50779107 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50700203 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50595313 |
| 31 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.49866069 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.49695674 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.48849081 |
| 34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.48849081 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47257921 |
| 36 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.44955456 |
| 37 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.43027152 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.42200680 |
| 39 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.41782244 |
| 40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.41625619 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40750624 |
| 42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.40380618 |
| 43 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.39292886 |
| 44 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.37476077 |
| 45 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36508389 |
| 46 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.35042334 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34558355 |
| 48 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33814372 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33480724 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.33128621 |
| 51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.32594040 |
| 52 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.32442315 |
| 53 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.32400114 |
| 54 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32346204 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32117314 |
| 56 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31435137 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31426949 |
| 58 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.31193069 |
| 59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29750003 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29557466 |
| 61 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.28897461 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27962938 |
| 63 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27335681 |
| 64 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.24887980 |
| 65 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.22895255 |
| 66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.21988836 |
| 67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.20903199 |
| 68 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.20321756 |
| 69 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.20104529 |
| 70 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19935389 |
| 71 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.19931325 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17636005 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17432773 |
| 74 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.17128533 |
| 75 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.16620612 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16490840 |
| 77 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.16307614 |
| 78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16218932 |
| 79 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16113305 |
| 80 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.14161328 |
| 81 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.13995702 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 1.13573106 |
| 83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13041253 |
| 84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12628526 |
| 85 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.12418822 |
| 86 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.12418822 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12355032 |
| 88 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10409616 |
| 89 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.06892617 |
| 90 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06814085 |
| 91 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05795819 |
| 92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.05014439 |
| 93 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04566214 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04211398 |
| 95 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02894596 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02207063 |
| 97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02198159 |
| 98 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.01223396 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01155929 |
| 100 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00661806 |
| 101 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.00619318 |
| 102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.00338504 |
| 103 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.99504539 |
| 104 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99487664 |
| 105 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99487664 |
| 106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99342818 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99140847 |
| 108 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99016239 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98583191 |
| 110 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.98397983 |
| 111 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.97878086 |
| 112 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97646446 |
| 113 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.97099508 |
| 114 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.95837172 |
| 115 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94971443 |
| 116 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.94448768 |
| 117 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93701308 |
| 118 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91830892 |
| 119 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91830623 |
| 120 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91774286 |
| 121 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90785316 |
| 122 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90695012 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90492396 |
| 124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90485773 |
| 125 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90148839 |
| 126 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88815749 |
| 127 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.88087199 |
| 128 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87568063 |
| 129 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86765772 |
| 130 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.86157411 |
| 131 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.85115554 |
| 132 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83330524 |
| 133 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.83012509 |
| 134 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.82535200 |
| 135 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82401904 |
| 136 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81925116 |
| 137 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80004027 |
| 138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79779611 |
| 139 | SA1_27219007_Chip-Seq_Bcells_Human | 0.79642363 |
| 140 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78286597 |
| 141 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77995796 |
| 142 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.76271716 |
| 143 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.76271716 |
| 144 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.76271716 |
| 145 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75943372 |
| 146 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75504095 |
| 147 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74756012 |
| 148 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73399686 |
| 149 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.72638920 |
| 150 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71396868 |
| 151 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.71240368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 7.31948124 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 4.96468914 |
| 3 | MP0003941_abnormal_skin_development | 4.73982806 |
| 4 | MP0005501_abnormal_skin_physiology | 4.37679977 |
| 5 | MP0005275_abnormal_skin_tensile | 4.31358297 |
| 6 | MP0009840_abnormal_foam_cell | 3.94649291 |
| 7 | MP0002735_abnormal_chemical_nociception | 3.24591628 |
| 8 | MP0004858_abnormal_nervous_system | 3.00146039 |
| 9 | MP0010771_integument_phenotype | 2.86800075 |
| 10 | MP0004381_abnormal_hair_follicle | 2.71427047 |
| 11 | MP0002254_reproductive_system_inflammat | 2.68318678 |
| 12 | MP0001216_abnormal_epidermal_layer | 2.65513869 |
| 13 | MP0005360_urolithiasis | 2.58574152 |
| 14 | MP0002060_abnormal_skin_morphology | 2.50003341 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.40997451 |
| 16 | MP0000579_abnormal_nail_morphology | 2.38542292 |
| 17 | MP0005451_abnormal_body_composition | 2.36295735 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.28002144 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.26778437 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.25789143 |
| 21 | MP0002736_abnormal_nociception_after | 2.16966896 |
| 22 | MP0002098_abnormal_vibrissa_morphology | 2.09327867 |
| 23 | MP0003453_abnormal_keratinocyte_physiol | 2.07439961 |
| 24 | MP0008995_early_reproductive_senescence | 2.02497799 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.89991256 |
| 26 | MP0004270_analgesia | 1.88996582 |
| 27 | MP0006276_abnormal_autonomic_nervous | 1.86799311 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.76961498 |
| 29 | MP0010678_abnormal_skin_adnexa | 1.75719702 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.74834365 |
| 31 | MP0004947_skin_inflammation | 1.74354631 |
| 32 | MP0000377_abnormal_hair_follicle | 1.72325942 |
| 33 | MP0005365_abnormal_bile_salt | 1.69572580 |
| 34 | MP0002009_preneoplasia | 1.67056312 |
| 35 | MP0001765_abnormal_ion_homeostasis | 1.65062483 |
| 36 | MP0000538_abnormal_urinary_bladder | 1.64961512 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.62680704 |
| 38 | MP0005409_darkened_coat_color | 1.60426381 |
| 39 | MP0000383_abnormal_hair_follicle | 1.60311182 |
| 40 | MP0005330_cardiomyopathy | 1.57793208 |
| 41 | MP0000427_abnormal_hair_cycle | 1.54689634 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.54098362 |
| 43 | MP0000647_abnormal_sebaceous_gland | 1.52899449 |
| 44 | MP0004043_abnormal_pH_regulation | 1.50645219 |
| 45 | MP0003091_abnormal_cell_migration | 1.49448024 |
| 46 | MP0000566_synostosis | 1.47463215 |
| 47 | MP0000462_abnormal_digestive_system | 1.45000007 |
| 48 | MP0005023_abnormal_wound_healing | 1.44960979 |
| 49 | MP0000467_abnormal_esophagus_morphology | 1.43661572 |
| 50 | MP0005388_respiratory_system_phenotype | 1.37463400 |
| 51 | MP0002133_abnormal_respiratory_system | 1.37463400 |
| 52 | MP0005332_abnormal_amino_acid | 1.36330635 |
| 53 | MP0000762_abnormal_tongue_morphology | 1.36263785 |
| 54 | MP0002734_abnormal_mechanical_nocicepti | 1.34629545 |
| 55 | MP0003329_amyloid_beta_deposits | 1.34022737 |
| 56 | MP0001191_abnormal_skin_condition | 1.33010695 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.32848677 |
| 58 | MP0005670_abnormal_white_adipose | 1.32064752 |
| 59 | MP0005257_abnormal_intraocular_pressure | 1.31906894 |
| 60 | MP0002295_abnormal_pulmonary_circulatio | 1.30332094 |
| 61 | MP0001970_abnormal_pain_threshold | 1.30252247 |
| 62 | MP0010030_abnormal_orbit_morphology | 1.26991946 |
| 63 | MP0009931_abnormal_skin_appearance | 1.26472920 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.25761713 |
| 65 | MP0001756_abnormal_urination | 1.25159117 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.22862989 |
| 67 | MP0008961_abnormal_basal_metabolism | 1.19233855 |
| 68 | MP0004233_abnormal_muscle_weight | 1.17500665 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 1.14288155 |
| 70 | MP0006138_congestive_heart_failure | 1.14241022 |
| 71 | MP0008260_abnormal_autophagy | 1.11658561 |
| 72 | MP0001346_abnormal_lacrimal_gland | 1.11627262 |
| 73 | MP0005083_abnormal_biliary_tract | 1.07934294 |
| 74 | MP0002909_abnormal_adrenal_gland | 1.07215215 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.02021611 |
| 76 | MP0008438_abnormal_cutaneous_collagen | 1.01109609 |
| 77 | MP0001986_abnormal_taste_sensitivity | 1.00709743 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.99319472 |
| 79 | MP0000750_abnormal_muscle_regeneration | 0.97802157 |
| 80 | MP0000367_abnormal_coat/_hair | 0.97240668 |
| 81 | MP0002089_abnormal_postnatal_growth/wei | 0.96746693 |
| 82 | MP0001849_ear_inflammation | 0.96626329 |
| 83 | MP0003879_abnormal_hair_cell | 0.96346770 |
| 84 | MP0001958_emphysema | 0.95381963 |
| 85 | MP0002822_catalepsy | 0.95277413 |
| 86 | MP0001661_extended_life_span | 0.93393889 |
| 87 | MP0001666_abnormal_nutrient_absorption | 0.92393607 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91822892 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.91209779 |
| 90 | MP0005085_abnormal_gallbladder_physiolo | 0.90835358 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90411656 |
| 92 | MP0002139_abnormal_hepatobiliary_system | 0.90018103 |
| 93 | MP0000627_abnormal_mammary_gland | 0.89349325 |
| 94 | MP0003315_abnormal_perineum_morphology | 0.88950719 |
| 95 | MP0009379_abnormal_foot_pigmentation | 0.88890181 |
| 96 | MP0010329_abnormal_lipoprotein_level | 0.88521152 |
| 97 | MP0009046_muscle_twitch | 0.87266876 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.87219740 |
| 99 | MP0003195_calcinosis | 0.86025175 |
| 100 | MP0004036_abnormal_muscle_relaxation | 0.85896950 |
| 101 | MP0003950_abnormal_plasma_membrane | 0.83184025 |
| 102 | MP0001177_atelectasis | 0.82681211 |
| 103 | MP0001340_abnormal_eyelid_morphology | 0.82117768 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.81683334 |
| 105 | MP0000477_abnormal_intestine_morphology | 0.80560940 |
| 106 | MP0003718_maternal_effect | 0.79614083 |
| 107 | MP0002108_abnormal_muscle_morphology | 0.78633895 |
| 108 | MP0001270_distended_abdomen | 0.77947740 |
| 109 | MP0001984_abnormal_olfaction | 0.77855708 |
| 110 | MP0000858_altered_metastatic_potential | 0.76449893 |
| 111 | MP0004084_abnormal_cardiac_muscle | 0.76435025 |
| 112 | MP0003786_premature_aging | 0.76163095 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.75804559 |
| 114 | MP0010368_abnormal_lymphatic_system | 0.74548240 |
| 115 | MP0004272_abnormal_basement_membrane | 0.72960999 |
| 116 | MP0009333_abnormal_splenocyte_physiolog | 0.72860918 |
| 117 | MP0002184_abnormal_innervation | 0.72026761 |
| 118 | MP0003878_abnormal_ear_physiology | 0.70376945 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.70376945 |
| 120 | MP0004147_increased_porphyrin_level | 0.70116312 |
| 121 | MP0003115_abnormal_respiratory_system | 0.68141791 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.67317842 |
| 123 | MP0000249_abnormal_blood_vessel | 0.66684812 |
| 124 | MP0002086_abnormal_extraembryonic_tissu | 0.66334278 |
| 125 | MP0000609_abnormal_liver_physiology | 0.65987653 |
| 126 | MP0001175_abnormal_lung_morphology | 0.65948370 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.65931489 |
| 128 | MP0001881_abnormal_mammary_gland | 0.65360910 |
| 129 | MP0001730_embryonic_growth_arrest | 0.64674178 |
| 130 | MP0000681_abnormal_thyroid_gland | 0.62296159 |
| 131 | MP0003866_abnormal_defecation | 0.61427487 |
| 132 | MP0001243_abnormal_dermal_layer | 0.61363950 |
| 133 | MP0002067_abnormal_sensory_capabilities | 0.60288998 |
| 134 | MP0000013_abnormal_adipose_tissue | 0.60225169 |
| 135 | MP0002751_abnormal_autonomic_nervous | 0.59655607 |
| 136 | MP0002876_abnormal_thyroid_physiology | 0.59465536 |
| 137 | MP0000372_irregular_coat_pigmentation | 0.57527815 |
| 138 | MP0001348_abnormal_lacrimal_gland | 0.57448507 |
| 139 | MP0008004_abnormal_stomach_pH | 0.57372685 |
| 140 | MP0000516_abnormal_urinary_system | 0.54346101 |
| 141 | MP0005367_renal/urinary_system_phenotyp | 0.54346101 |
| 142 | MP0000747_muscle_weakness | 0.52826780 |
| 143 | MP0000604_amyloidosis | 0.52720536 |
| 144 | MP0000751_myopathy | 0.52655638 |
| 145 | MP0010352_gastrointestinal_tract_polyps | 0.52448876 |
| 146 | MP0000534_abnormal_ureter_morphology | 0.51917273 |
| 147 | MP0001542_abnormal_bone_strength | 0.51902833 |
| 148 | MP0000537_abnormal_urethra_morphology | 0.51271236 |
| 149 | MP0003045_fibrosis | 0.51144651 |
| 150 | MP0003183_abnormal_peptide_metabolism | 0.50330141 |
| 151 | MP0000230_abnormal_systemic_arterial | 0.50161559 |
| 152 | MP0002896_abnormal_bone_mineralization | 0.48382529 |
| 153 | MP0001851_eye_inflammation | 0.46560909 |
| 154 | MP0004885_abnormal_endolymph | 0.46519995 |
| 155 | MP0001664_abnormal_digestion | 0.43400792 |
| 156 | MP0008874_decreased_physiological_sensi | 0.40983128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Interstitial pulmonary disease (HP:0006530) | 9.94216329 |
| 2 | Ulnar claw (HP:0001178) | 5.74200795 |
| 3 | Hypotrichosis (HP:0001006) | 5.21530199 |
| 4 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.88008872 |
| 5 | Parakeratosis (HP:0001036) | 4.68028331 |
| 6 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.54540663 |
| 7 | Lip pit (HP:0100267) | 4.25147606 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 4.10810178 |
| 9 | Hypomagnesemia (HP:0002917) | 3.95781404 |
| 10 | Ependymoma (HP:0002888) | 3.84308117 |
| 11 | Plantar hyperkeratosis (HP:0007556) | 3.81030901 |
| 12 | Palmoplantar hyperkeratosis (HP:0000972) | 3.77145496 |
| 13 | Woolly hair (HP:0002224) | 3.74618338 |
| 14 | Increased IgE level (HP:0003212) | 3.70536005 |
| 15 | Hypokalemic alkalosis (HP:0001949) | 3.70481929 |
| 16 | Distal lower limb muscle weakness (HP:0009053) | 3.66959711 |
| 17 | Hyperactive renin-angiotensin system (HP:0000841) | 3.65947882 |
| 18 | Popliteal pterygium (HP:0009756) | 3.55517348 |
| 19 | Erythema (HP:0010783) | 3.53975606 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 3.53267832 |
| 21 | Increased circulating renin level (HP:0000848) | 3.52621046 |
| 22 | Gout (HP:0001997) | 3.51320262 |
| 23 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.51045171 |
| 24 | Abnormality of magnesium homeostasis (HP:0004921) | 3.46131413 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.44546996 |
| 26 | Palmar hyperkeratosis (HP:0010765) | 3.42039448 |
| 27 | Conjunctival hamartoma (HP:0100780) | 3.40940530 |
| 28 | Abnormality of nail color (HP:0100643) | 3.39403335 |
| 29 | Metabolic alkalosis (HP:0200114) | 3.37259938 |
| 30 | Abnormality of chloride homeostasis (HP:0011422) | 3.32302792 |
| 31 | Alveolar cell carcinoma (HP:0006519) | 3.17024690 |
| 32 | Respiratory distress (HP:0002098) | 3.13824528 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.06326066 |
| 34 | Corneal erosion (HP:0200020) | 3.04951704 |
| 35 | Natal tooth (HP:0000695) | 3.00834353 |
| 36 | Advanced eruption of teeth (HP:0006288) | 2.99867046 |
| 37 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.97138577 |
| 38 | Pili torti (HP:0003777) | 2.91470840 |
| 39 | Abnormal hemoglobin (HP:0011902) | 2.89430272 |
| 40 | Distal lower limb amyotrophy (HP:0008944) | 2.83547247 |
| 41 | Fragile nails (HP:0001808) | 2.82078484 |
| 42 | Erythroderma (HP:0001019) | 2.80235160 |
| 43 | Dehydration (HP:0001944) | 2.78397842 |
| 44 | Ventricular fibrillation (HP:0001663) | 2.74642044 |
| 45 | Abnormality of renal excretion (HP:0011036) | 2.73688147 |
| 46 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.72855173 |
| 47 | Polyuria (HP:0000103) | 2.70602418 |
| 48 | Hypokinesia (HP:0002375) | 2.70151865 |
| 49 | Vertebral compression fractures (HP:0002953) | 2.69361259 |
| 50 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.68311888 |
| 51 | Hydroxyprolinuria (HP:0003080) | 2.64347737 |
| 52 | Abnormality of proline metabolism (HP:0010907) | 2.64347737 |
| 53 | Abnormal urine output (HP:0012590) | 2.63828398 |
| 54 | Curly hair (HP:0002212) | 2.60780025 |
| 55 | Steppage gait (HP:0003376) | 2.59852587 |
| 56 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.59730306 |
| 57 | Mitral stenosis (HP:0001718) | 2.56409617 |
| 58 | Vascular calcification (HP:0004934) | 2.52840471 |
| 59 | Nail dystrophy (HP:0008404) | 2.52631094 |
| 60 | Amelogenesis imperfecta (HP:0000705) | 2.50408990 |
| 61 | Tachypnea (HP:0002789) | 2.49463141 |
| 62 | Renal salt wasting (HP:0000127) | 2.49410179 |
| 63 | Proximal tubulopathy (HP:0000114) | 2.48710479 |
| 64 | Onycholysis (HP:0001806) | 2.48123655 |
| 65 | Astrocytoma (HP:0009592) | 2.47700926 |
| 66 | Abnormality of the astrocytes (HP:0100707) | 2.47700926 |
| 67 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.46303925 |
| 68 | Abdominal distention (HP:0003270) | 2.44613038 |
| 69 | Xanthomatosis (HP:0000991) | 2.43311157 |
| 70 | Areflexia of lower limbs (HP:0002522) | 2.42766954 |
| 71 | Abnormality of secondary sexual hair (HP:0009888) | 2.42094624 |
| 72 | Abnormality of the axillary hair (HP:0100134) | 2.42094624 |
| 73 | Abnormal blistering of the skin (HP:0008066) | 2.41196802 |
| 74 | Myokymia (HP:0002411) | 2.40209919 |
| 75 | Hypohidrosis (HP:0000966) | 2.37327863 |
| 76 | Stomach cancer (HP:0012126) | 2.34431898 |
| 77 | Hyperglycinuria (HP:0003108) | 2.33484751 |
| 78 | Glomerulonephritis (HP:0000099) | 2.32282520 |
| 79 | Trismus (HP:0000211) | 2.32115251 |
| 80 | Seborrheic dermatitis (HP:0001051) | 2.30734057 |
| 81 | Foot dorsiflexor weakness (HP:0009027) | 2.29341423 |
| 82 | Growth hormone excess (HP:0000845) | 2.28413056 |
| 83 | Abnormality of renin-angiotensin system (HP:0000847) | 2.26784001 |
| 84 | Alkalosis (HP:0001948) | 2.26198916 |
| 85 | Abnormal hair laboratory examination (HP:0003328) | 2.25616853 |
| 86 | Down-sloping shoulders (HP:0200021) | 2.25609011 |
| 87 | Sparse scalp hair (HP:0002209) | 2.22541723 |
| 88 | Hyperaldosteronism (HP:0000859) | 2.21851621 |
| 89 | Malnutrition (HP:0004395) | 2.21404808 |
| 90 | Premature rupture of membranes (HP:0001788) | 2.20773364 |
| 91 | Abnormality of the vocal cords (HP:0008777) | 2.20666336 |
| 92 | Cardiovascular calcification (HP:0011915) | 2.19727909 |
| 93 | Increased purine levels (HP:0004368) | 2.19594998 |
| 94 | Hyperuricemia (HP:0002149) | 2.19594998 |
| 95 | Abnormality of complement system (HP:0005339) | 2.18962984 |
| 96 | Adrenal overactivity (HP:0002717) | 2.16644607 |
| 97 | Hypobetalipoproteinemia (HP:0003563) | 2.15650847 |
| 98 | Facial shape deformation (HP:0011334) | 2.13723940 |
| 99 | Potter facies (HP:0002009) | 2.13723940 |
| 100 | Widely patent fontanelles and sutures (HP:0004492) | 2.13337133 |
| 101 | Increased connective tissue (HP:0009025) | 2.13056288 |
| 102 | Wide cranial sutures (HP:0010537) | 2.13016243 |
| 103 | Severe Myopia (HP:0011003) | 2.12508356 |
| 104 | Acanthosis nigricans (HP:0000956) | 2.12337845 |
| 105 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11447776 |
| 106 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11447776 |
| 107 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11447776 |
| 108 | Hypercortisolism (HP:0001578) | 2.11437593 |
| 109 | Hypothermia (HP:0002045) | 2.10490682 |
| 110 | Hyperacusis (HP:0010780) | 2.10314484 |
| 111 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.10136537 |
| 112 | Fasciculations (HP:0002380) | 2.09919260 |
| 113 | Onion bulb formation (HP:0003383) | 2.06559570 |
| 114 | Distal arthrogryposis (HP:0005684) | 2.05049627 |
| 115 | Hypolipoproteinemia (HP:0010981) | 2.05027504 |
| 116 | Glycosuria (HP:0003076) | 2.03807536 |
| 117 | Abnormality of urine glucose concentration (HP:0011016) | 2.03807536 |
| 118 | Ileus (HP:0002595) | 2.02152785 |
| 119 | Thin bony cortex (HP:0002753) | 2.01898853 |
| 120 | Loss of speech (HP:0002371) | 2.01344214 |
| 121 | Action tremor (HP:0002345) | 2.00305217 |
| 122 | Abnormality of purine metabolism (HP:0004352) | 1.99125214 |
| 123 | Abnormal drinking behavior (HP:0030082) | 1.98894844 |
| 124 | Polydipsia (HP:0001959) | 1.98894844 |
| 125 | Ectropion (HP:0000656) | 1.98406200 |
| 126 | Short nail (HP:0001799) | 1.98317316 |
| 127 | Palmoplantar keratoderma (HP:0000982) | 1.96913596 |
| 128 | Hyperparathyroidism (HP:0000843) | 1.96570911 |
| 129 | Gangrene (HP:0100758) | 1.96383359 |
| 130 | Nonimmune hydrops fetalis (HP:0001790) | 1.95908881 |
| 131 | Abnormality of the foot musculature (HP:0001436) | 1.95485944 |
| 132 | Pruritus (HP:0000989) | 1.94992554 |
| 133 | Tubulointerstitial fibrosis (HP:0005576) | 1.94620693 |
| 134 | Truncus arteriosus (HP:0001660) | 1.94080048 |
| 135 | Rickets (HP:0002748) | 1.93915783 |
| 136 | Neoplasm of head and neck (HP:0012288) | 1.93908258 |
| 137 | Esophageal neoplasm (HP:0100751) | 1.93908258 |
| 138 | Hypoplasia of the uterus (HP:0000013) | 1.93806142 |
| 139 | Abnormality of the costochondral junction (HP:0000919) | 1.93676097 |
| 140 | Complement deficiency (HP:0004431) | 1.92431890 |
| 141 | Abnormality of the salivary glands (HP:0010286) | 1.92399731 |
| 142 | Lack of skin elasticity (HP:0100679) | 1.91754318 |
| 143 | Renal tubular acidosis (HP:0001947) | 1.90710997 |
| 144 | Fat malabsorption (HP:0002630) | 1.90652344 |
| 145 | Sparse eyelashes (HP:0000653) | 1.90522808 |
| 146 | Hamartoma of the eye (HP:0010568) | 1.89647268 |
| 147 | Hyperphosphaturia (HP:0003109) | 1.89608644 |
| 148 | Hammertoe (HP:0001765) | 1.88758556 |
| 149 | Cervical subluxation (HP:0003308) | 1.86767174 |
| 150 | Delayed epiphyseal ossification (HP:0002663) | 1.86195001 |
| 151 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86007565 |
| 152 | Osteolytic defects of the hand bones (HP:0009699) | 1.86007565 |
| 153 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86003462 |
| 154 | Mucopolysacchariduria (HP:0008155) | 1.86003462 |
| 155 | Prolonged neonatal jaundice (HP:0006579) | 1.85707784 |
| 156 | Akinesia (HP:0002304) | 1.84731959 |
| 157 | Alopecia of scalp (HP:0002293) | 1.84663375 |
| 158 | Upper limb amyotrophy (HP:0009129) | 1.84596260 |
| 159 | Distal upper limb amyotrophy (HP:0007149) | 1.84596260 |
| 160 | Glioma (HP:0009733) | 1.82104940 |
| 161 | Bronchomalacia (HP:0002780) | 1.81550691 |
| 162 | Bone pain (HP:0002653) | 1.81256892 |
| 163 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.80984372 |
| 164 | Hypotension (HP:0002615) | 1.79938688 |
| 165 | Stridor (HP:0010307) | 1.78830777 |
| 166 | Cerebral aneurysm (HP:0004944) | 1.78753642 |
| 167 | Cerebral palsy (HP:0100021) | 1.76442970 |
| 168 | Esophageal varix (HP:0002040) | 1.76277736 |
| 169 | Hypoalphalipoproteinemia (HP:0003233) | 1.74501329 |
| 170 | Abnormal tarsal ossification (HP:0008369) | 1.73851770 |
| 171 | Abnormality of the fingertips (HP:0001211) | 1.73775942 |
| 172 | Lower limb amyotrophy (HP:0007210) | 1.73174303 |
| 173 | Nephritis (HP:0000123) | 1.72581193 |
| 174 | Abnormal glucose tolerance (HP:0001952) | 1.67788699 |
| 175 | Abnormality of carpal bone ossification (HP:0006257) | 1.67468690 |
| 176 | Glomerulosclerosis (HP:0000096) | 1.66097064 |
| 177 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.64535614 |
| 178 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.64535614 |
| 179 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.64535614 |
| 180 | Bulbar palsy (HP:0001283) | 1.64289473 |
| 181 | Atelectasis (HP:0100750) | 1.63776872 |
| 182 | Supranuclear gaze palsy (HP:0000605) | 1.63429071 |
| 183 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.62435942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 5.82315276 |
| 2 | EPHA2 | 5.68475228 |
| 3 | MAPKAPK3 | 4.91946276 |
| 4 | WNK4 | 4.03134908 |
| 5 | MAP3K2 | 3.37064753 |
| 6 | MST4 | 3.18477426 |
| 7 | NTRK1 | 2.99681102 |
| 8 | PBK | 2.90128700 |
| 9 | MST1R | 2.84892836 |
| 10 | FER | 2.74645385 |
| 11 | OXSR1 | 2.69320022 |
| 12 | LMTK2 | 2.48706472 |
| 13 | TRIB3 | 2.46895134 |
| 14 | MAP3K9 | 2.36145547 |
| 15 | STK39 | 2.35091661 |
| 16 | NME1 | 2.32432017 |
| 17 | WNK3 | 2.24761546 |
| 18 | MINK1 | 2.08242329 |
| 19 | GRK5 | 2.08101731 |
| 20 | SIK1 | 2.06215046 |
| 21 | LIMK1 | 2.03251289 |
| 22 | LATS2 | 2.01826371 |
| 23 | PAK4 | 1.98866549 |
| 24 | EPHB2 | 1.91316049 |
| 25 | SMG1 | 1.90389627 |
| 26 | MATK | 1.89947459 |
| 27 | MAP3K3 | 1.81306524 |
| 28 | MAP3K12 | 1.69835876 |
| 29 | KSR2 | 1.68316579 |
| 30 | WNK1 | 1.67289041 |
| 31 | RPS6KB2 | 1.51401450 |
| 32 | TESK2 | 1.45015958 |
| 33 | EPHA3 | 1.44968164 |
| 34 | MAPKAPK5 | 1.42865863 |
| 35 | FGFR4 | 1.39338611 |
| 36 | MAP3K6 | 1.35321444 |
| 37 | NTRK3 | 1.27518633 |
| 38 | TRPM7 | 1.18253443 |
| 39 | ICK | 1.15713493 |
| 40 | LRRK2 | 1.15552018 |
| 41 | TESK1 | 1.13502700 |
| 42 | PIM2 | 1.13367205 |
| 43 | MAP2K4 | 1.11028168 |
| 44 | MAP2K1 | 1.07533779 |
| 45 | GRK7 | 1.06944142 |
| 46 | PRKG2 | 1.05385868 |
| 47 | LATS1 | 0.99030387 |
| 48 | RET | 0.97545743 |
| 49 | MAP2K2 | 0.96156029 |
| 50 | MAP3K1 | 0.93934025 |
| 51 | NME2 | 0.93074971 |
| 52 | MAP3K11 | 0.92431934 |
| 53 | ZAP70 | 0.90913393 |
| 54 | PDGFRA | 0.90054684 |
| 55 | PRPF4B | 0.88947657 |
| 56 | ADRBK1 | 0.85951866 |
| 57 | MET | 0.84937142 |
| 58 | PKN2 | 0.83760994 |
| 59 | PHKG2 | 0.82842795 |
| 60 | PHKG1 | 0.82842795 |
| 61 | MAP2K6 | 0.82785979 |
| 62 | STK38 | 0.82108124 |
| 63 | ERN1 | 0.81800830 |
| 64 | BCKDK | 0.80675227 |
| 65 | SGK494 | 0.79744974 |
| 66 | SGK223 | 0.79744974 |
| 67 | PTK2 | 0.79284355 |
| 68 | ABL2 | 0.78750693 |
| 69 | TAOK1 | 0.77771984 |
| 70 | STK38L | 0.76971789 |
| 71 | RPS6KA2 | 0.75395576 |
| 72 | TGFBR2 | 0.73747576 |
| 73 | RIPK4 | 0.72175780 |
| 74 | CDK7 | 0.71603800 |
| 75 | PTK6 | 0.70945233 |
| 76 | NEK1 | 0.70940033 |
| 77 | PDK4 | 0.70884008 |
| 78 | PDK3 | 0.70884008 |
| 79 | BCR | 0.66952022 |
| 80 | FGFR3 | 0.65931401 |
| 81 | PIK3CG | 0.65659807 |
| 82 | MAPK11 | 0.65106462 |
| 83 | MAP3K7 | 0.64967178 |
| 84 | TNK2 | 0.64782692 |
| 85 | PAK3 | 0.62017474 |
| 86 | NEK9 | 0.59240445 |
| 87 | ILK | 0.59220530 |
| 88 | FRK | 0.58908244 |
| 89 | DMPK | 0.57648875 |
| 90 | MTOR | 0.57547510 |
| 91 | KDR | 0.57474283 |
| 92 | EPHB1 | 0.55495238 |
| 93 | BUB1 | 0.53954107 |
| 94 | ROCK1 | 0.53513530 |
| 95 | BRSK1 | 0.52451240 |
| 96 | MAPK15 | 0.50198888 |
| 97 | PINK1 | 0.50086535 |
| 98 | MAP3K8 | 0.49828746 |
| 99 | PRKCE | 0.48948084 |
| 100 | ARAF | 0.48820596 |
| 101 | GRK1 | 0.48794105 |
| 102 | PRKCI | 0.47696386 |
| 103 | CAMK2B | 0.47522784 |
| 104 | PDK2 | 0.47516177 |
| 105 | BMX | 0.47274232 |
| 106 | MELK | 0.46971503 |
| 107 | MYLK | 0.46728179 |
| 108 | STK24 | 0.46411805 |
| 109 | FLT3 | 0.44788355 |
| 110 | NTRK2 | 0.44681586 |
| 111 | IRAK1 | 0.43793506 |
| 112 | CDK8 | 0.43166198 |
| 113 | MARK2 | 0.41766763 |
| 114 | MAPKAPK2 | 0.40886740 |
| 115 | STK10 | 0.38946297 |
| 116 | BMPR1B | 0.38329722 |
| 117 | BLK | 0.38213426 |
| 118 | EGFR | 0.36548531 |
| 119 | CDK5 | 0.34923867 |
| 120 | PRKD2 | 0.34734715 |
| 121 | PRKD1 | 0.34599530 |
| 122 | STK11 | 0.34502156 |
| 123 | DYRK1B | 0.34233013 |
| 124 | FGFR2 | 0.33414190 |
| 125 | GSK3A | 0.32919792 |
| 126 | CAMK2D | 0.32672214 |
| 127 | CAMK2G | 0.32616335 |
| 128 | PRKACA | 0.32058503 |
| 129 | CSNK1E | 0.31593744 |
| 130 | PDGFRB | 0.30935777 |
| 131 | PRKCZ | 0.30920853 |
| 132 | TYRO3 | 0.30682944 |
| 133 | RIPK1 | 0.29299303 |
| 134 | PDPK1 | 0.29210988 |
| 135 | EEF2K | 0.28933944 |
| 136 | MUSK | 0.27755977 |
| 137 | SGK2 | 0.27506708 |
| 138 | PRKACG | 0.27488704 |
| 139 | PRKCA | 0.27344291 |
| 140 | CDC42BPA | 0.27321317 |
| 141 | EIF2AK1 | 0.26622783 |
| 142 | ERBB2 | 0.26523355 |
| 143 | PRKCG | 0.26405164 |
| 144 | PAK1 | 0.25583506 |
| 145 | TAOK2 | 0.22486473 |
| 146 | DAPK3 | 0.21532731 |
| 147 | CDK9 | 0.21393567 |
| 148 | PRKD3 | 0.20263522 |
| 149 | AURKA | 0.18949474 |
| 150 | DAPK1 | 0.18148298 |
| 151 | CHUK | 0.17939684 |
| 152 | AURKB | 0.17556608 |
| 153 | HIPK2 | 0.17352057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.45333789 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.10673750 |
| 3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.94800221 |
| 4 | Galactose metabolism_Homo sapiens_hsa00052 | 2.70849869 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.61937283 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.42019121 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.41508079 |
| 8 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.19120483 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.95376264 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74546667 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.72303308 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.70952891 |
| 13 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.64302160 |
| 14 | Mineral absorption_Homo sapiens_hsa04978 | 1.64046437 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.63292726 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 1.59846313 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58740503 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.57431637 |
| 19 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.56006280 |
| 20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53630618 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.52216817 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.47594089 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46254025 |
| 24 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.45001841 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41771117 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.29759889 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.29175004 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28757468 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.25976445 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17923688 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17036221 |
| 32 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.16806831 |
| 33 | Adherens junction_Homo sapiens_hsa04520 | 1.15973299 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15610290 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.13881910 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13175938 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.10515468 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10300146 |
| 39 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.07200106 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05001881 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.03584739 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03417213 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.00336509 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99189529 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97760063 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97402070 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.97006344 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92714529 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92417090 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90108501 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88213702 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88081222 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86060865 |
| 54 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.85720322 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85308168 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85300370 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84543277 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84450373 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.83018098 |
| 60 | Taste transduction_Homo sapiens_hsa04742 | 0.82583866 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78217609 |
| 62 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75087187 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75080312 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71782628 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 0.70941807 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.70681121 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.70531732 |
| 68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69642493 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69131099 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69008931 |
| 71 | Tight junction_Homo sapiens_hsa04530 | 0.68568330 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68326278 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68223808 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68198921 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.67839220 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66632738 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65153375 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.64962791 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64854397 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64541727 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64436911 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63884616 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63022261 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62566145 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62183184 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62171867 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61967835 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60389310 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59395124 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59289371 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58237424 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.57635063 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57402908 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57367730 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57145190 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56860885 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56383628 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.56286789 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54139677 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53023039 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52664960 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51647796 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51573119 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50536882 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.49818316 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49334695 |
| 107 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48762535 |
| 108 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48319090 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45372605 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44970648 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.44270286 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.42927036 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | 0.42811417 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42767638 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42220848 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.41028277 |
| 117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.40856502 |
| 118 | Melanogenesis_Homo sapiens_hsa04916 | 0.40477829 |
| 119 | Lysosome_Homo sapiens_hsa04142 | 0.39012497 |
| 120 | Insulin secretion_Homo sapiens_hsa04911 | 0.38794587 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.37219875 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36913135 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35994905 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35892822 |
| 125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.35718204 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35461308 |
| 127 | Melanoma_Homo sapiens_hsa05218 | 0.34132354 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33745570 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31233892 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31006222 |
| 131 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30371529 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27827491 |
| 133 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.24291070 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23923572 |
| 135 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.23696230 |
| 136 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22974917 |
| 137 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.22414734 |
| 138 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.21652183 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21158131 |

